Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifidobacterium and Lactobacillus Triplex Tablets for Antibiotic-associated Diarrhea in Children
ChiCTR2100044914Phase 4Recruiting
- Sponsor
- West China Second University Hospital
- Start
- Apr 2021
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of Golden Bifid in antibiotic-associated diarrhea (AAD) (2 arms), sponsored by West China Second University Hospital. Primary endpoints: Blood routine examination, Serum inflammatory cytokines and 2 more. Started Apr 2021; status: recruiting.
02
Drugs
Golden Bifid
03
Conditions
antibiotic-associated diarrhea (AAD)
Beyond the preview
Go deeper on ChiCTR2100044914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044914.